Myriad Genetics Inc
XETRA:MYD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Myriad Genetics Inc
XETRA:MYD
|
US |
|
A
|
Archer-Daniels-Midland Co
SWB:ADM
|
US |
|
S
|
Sasol Ltd
DUS:SAOA
|
ZA |
|
T
|
Tmp Group SpA
MIL:TMP
|
IT |
|
CLPS Inc
F:1UK
|
CN |
|
Super Micro Computer Inc
F:MS51
|
US |
|
MONY Group PLC
LSE:MONY
|
UK |
|
G
|
Goldman Sachs BDC Inc
F:GSB
|
US |
|
H
|
Home Depot Inc
DUS:HDI
|
US |
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for Myriad Genetics Inc.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Myriad Genetics Does
Myriad Genetics makes genetic tests that help doctors understand a patient’s risk for certain diseases and choose treatment more precisely. Its core products are laboratory tests in areas such as hereditary cancer, women’s health, and some pharmacogenomic tests that look at how a person may respond to a medicine. The company sells these tests through physicians, hospitals, and health systems, and it gets paid when the tests are ordered and processed.
- Headquarters
- United States of America US
- Employees
- 2 700
- IPO date
- Oct 6, 1995